Letermovir prophylaxis for cytomegalovirus is associated with risk of post-transplant lymphoproliferative disorders after haploidentical stem cell transplantation

Letermovir prophylaxis for cytomegalovirus is associated with risk of post-transplant lymphoproliferative disorders after haploidentical stem cell transplantation

Not available.

Saved in:

Bibliographic Details
Main Authors:	Xu-Ying Pei, Qiang Huang, Ling-Jie Luo, Hai-Lu Sun, Jing Liu, Yu-Qian Sun, Xiao-Dong Mo, Meng Lv, Dai-Hong Liu, Hong-Yan Ma, Yan-Wei Wu, Lan-Ping Xu, Yu Wang, Xiao-Hui Zhang, Liang Chen, Xiao-Jun Huang
Format:	Article
Language:	English
Published:	Ferrata Storti Foundation 2024-11-01
Series:	Haematologica
Online Access:	https://haematologica.org/article/view/11851
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Letermovir use for cytomegalovirus prophylaxis following lung transplantation: A single-center review
by: Alyssa K. Mezochow, MD, MSc, et al.
Published: (2024-11-01)

Epstein-Barr virus infection following allogeneic hematopoietic stem cell transplantation in the era of letermovir for cytomegalovirus prophylaxis
by: Jingtao Huang, et al.
Published: (2025-05-01)

LETERMOVIR PRIMARY CYTOMEGALOVIRUS PROPHYLAXIS IN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS: COULD INFECTION AND DISEASE NO LONGER BE A SIGNIFICANT PROBLEM?
by: Fabian Herrera
Published: (2024-04-01)

HAPLOIDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR PAEDIATRIC PATIENTS WITH X-LINKED LYMPHOPROLIFERATIVE SYNDROME
by: Yuan Sun
Published: (2024-04-01)

Randomized trial of anti-thymocyte globulin plus low-dose post-transplant cyclophosphamide to prevent graft-versus-host disease in haploidentical transplantation
by: Zheng-Li Xu, et al.
Published: (2025-06-01)

Distinct Immune Homeostasis Remodeling Patterns after HLA‐Matched and Haploidentical Transplantation
by: Huidong Guo, et al.
Published: (2024-10-01)

Immune Reconstitution after Haploidentical Hematopoietic Stem Cell Transplantation with Different Non‐T‐Cell Depletion Protocols
by: Xiao‐Di Ma, et al.
Published: (2025-06-01)

In Vivo Emergence of UL56 C325Y Cytomegalovirus Resistance to Letermovir in a Patient with Acute Myeloid Leukemia after Hematopoietic Cell Transplantation
by: Jochen J Frietsch, et al.
Published: (2019-01-01)

Real-world efficacy and safety of letermovir versus ganciclovir prophylaxis in adolescent patients undergoing allogenic hematopoietic stem cell transplantation: a single center observational study
by: Ziwei Xu, et al.
Published: (2025-06-01)

Identification of a binding pocket of letermovir in the terminase subunit pUL56 of human cytomegalovirus
by: Lukas M. Kmetsch, et al.
Published: (2025-03-01)

Post-transplant cyclophosphamide in haploidentical stem cell transplantation: evaluating the impact of transplant conditioning intensity
by: Umberto Pizzano, et al.
Published: (2025-08-01)

Haploidentical Stem Cell Transplantation With Dual Source of Cells and Post‐Transplant Cyclophosphamide
by: Ana Marcela Rojas Fonseca‐Hial, et al.
Published: (2025-02-01)

Post-transplant cyclophosphamide or cell selection in haploidentical allogeneic hematopoietic cell transplantation?
by: Razan Mohty, et al.
Published: (2024-12-01)

Haploidentical Transplantation in Children with Acute Leukemia: The Unresolved Issues
by: Sarita Rani Jaiswal, et al.
Published: (2016-01-01)

Future directions in haploidentical hematopoietic stem cell transplantation
by: Pongthep Vittayawacharin, et al.
Published: (2024-12-01)

Haploidentical Stem Cell Transplantation in Adult Haematological Malignancies
by: Kevon Parmesar, et al.
Published: (2016-01-01)

Pharmacokinetics of post-transplant cyclophosphamide and its associations with clinical outcomes in pediatric haploidentical hematopoietic stem cell transplantation
by: Kyung Taek Hong, et al.
Published: (2025-03-01)

Cytomegalovirus infection and drug resistance emergence during letermovir salvage therapy in a pediatric SCID patient
by: Fien Horsten, et al.
Published: (2025-05-01)

Cytomegalovirus mismatch after heart transplantation: Impact of antiviral prophylaxis and intravenous hyperimmune globulin
by: Moritz B. Immohr, et al.
Published: (2021-12-01)

Viral enteritis after allogeneic hematopoietic stem cell transplantation: pathogens, clinical characteristics, and outcomes
by: Hai-Lu Sun, et al.
Published: (2025-08-01)

Risk factors and clinical outcomes of cytomegalovirus infection following haploidentical hematopoietic stem cell transplantation in patients with aplastic anemia: a single-center retrospective study
by: Jia Feng, et al.
Published: (2025-01-01)

Posttransplant Lymphoproliferative Disease after Lung Transplantation
by: Isabel P. Neuringer
Published: (2013-01-01)

Correction: Pharmacokinetics of post-transplant cyclophosphamide and its associations with clinical outcomes in pediatric haploidentical hematopoietic stem cell transplantation
by: Kyung Taek Hong, et al.
Published: (2025-04-01)

IMMUNITY TO INFECTIONS AFTER HAPLOIDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION
by: Franco Aversa, et al.
Published: (2016-10-01)

Current status of conditioning regimens in haploidentical hematopoietic cell transplantation
by: Junichi Sugita, et al.
Published: (2024-12-01)

Evaluation of cytomegalovirus infection/disease in IgG positive renal transplantation recipients on valaciclovir prophylaxis
by: Tugba Sari, et al.
Published: (2022-12-01)

Does Cytomegalovirus Develop Resistance following Antiviral Prophylaxis and Treatment in Renal Transplant Patients in Kuwait?
by: Nada Madi, et al.
Published: (2011-01-01)

ADULT T-CELL LEUKEMIA/LYMPHOMA RELAPSED AFTER AUTOLOGOUS TRANSPLANT AND TREATED WITH HAPLOIDENTICAL STEM CELL TRANSPLANT
by: TFN Araújo, et al.
Published: (2024-10-01)

Comparable Outcomes for Hematologic Malignancies after HLA-Haploidentical Transplantation with Posttransplantation Cyclophosphamide and HLA-Matched Transplantation
by: Shannon R. McCurdy, et al.
Published: (2015-01-01)

Haploidentical Hematopoietic Stem Cell Transplantation: Expanding the Horizon for Hematologic Disorders
by: Mohammad Faizan Zahid, et al.
Published: (2016-01-01)

Natural Killer (NK) Cell Alloreactivity in Haploidentical Stem Cell Transplantation
by: Mar Luis-Hidalgo, et al.
Published: (2025-07-01)

Case Report: Maribavir for refractory cytomegalovirus viremia after renal transplantation in a child with Schimke’s immune-osseous dysplasia
by: Jia-Shuan Huang, et al.
Published: (2025-04-01)

Haploidentical, matched-related, and matched-unrelated hematopoietic cell transplant for acute leukemias in the early years of haploidentical transplant implementation in a developing country with a large unrelated donor registry
by: Adriana Seber, et al.
Published: (2025-04-01)

Impact of haplo-donor age on transplant outcomes: a comparative analysis of haploidentical vs cord blood transplantation
by: Takashi Nagayama, et al.
Published: (2025-07-01)

Post-transplant lymphoproliferative disorder in adult renal transplant recipients: case series and review of literature
by: Dorota Kamińska, et al.
Published: (2021-01-01)

Posttransplant Lymphoproliferative Disease after Pediatric Solid Organ Transplantation
by: Martin Mynarek, et al.
Published: (2013-01-01)

Valacyclovir versus valganciclovir for cytomegalovirus prophylaxis in kidney transplant recipients: a systematic review and comparative meta-analysis
by: Leonardo Januário Campos Cardoso, et al.
Published: (2025-03-01)

Triple stem cell infusion alleviated graft-versus-host disease and improves outcomes in unmanipulated haploidentical hematopoietic stem cell transplantation
by: Fang Hua, et al.
Published: (2025-07-01)

Intermediate-dose posttransplantation cyclophosphamide for myeloablative HLA-haploidentical bone marrow transplantation
by: Mustafa A. Hyder, et al.
Published: (2025-05-01)

Limiting the Impact of Methicillin Resistant Staphylococcus Aureus in Patients Undergoing Haploidentical Transplantation
by: SUPARNO CHAKRABARTI, et al.
Published: (2020-04-01)